These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 11875988)
1. Severe combined immunodeficiencies of the common gamma-chain/JAK3 signaling pathway. Schumacher RF; Notarangelo LD Isr Med Assoc J; 2002 Feb; 4(2):131-5. PubMed ID: 11875988 [No Abstract] [Full Text] [Related]
2. Human lung myofibroblasts as effectors of the inflammatory process: the common receptor gamma chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF-alpha. Doucet C; Giron-Michel J; Canonica GW; Azzarone B Eur J Immunol; 2002 Sep; 32(9):2437-49. PubMed ID: 12207328 [TBL] [Abstract][Full Text] [Related]
3. Jak3 and the pathogenesis of severe combined immunodeficiency. O'Shea JJ; Husa M; Li D; Hofmann SR; Watford W; Roberts JL; Buckley RH; Changelian P; Candotti F Mol Immunol; 2004 Jul; 41(6-7):727-37. PubMed ID: 15220007 [TBL] [Abstract][Full Text] [Related]
4. A partial deficiency of interleukin-7R alpha is sufficient to abrogate T-cell development and cause severe combined immunodeficiency. Roifman CM; Zhang J; Chitayat D; Sharfe N Blood; 2000 Oct; 96(8):2803-7. PubMed ID: 11023514 [TBL] [Abstract][Full Text] [Related]
5. A new modality for immunosuppression: targeting the JAK/STAT pathway. O'Shea JJ; Pesu M; Borie DC; Changelian PS Nat Rev Drug Discov; 2004 Jul; 3(7):555-64. PubMed ID: 15232577 [No Abstract] [Full Text] [Related]
6. Cytokine-mediated signalling and early defects in lymphoid development. Giliani S; Mella P; Savoldi G; Mazzolari E Curr Opin Allergy Clin Immunol; 2005 Dec; 5(6):519-24. PubMed ID: 16264332 [TBL] [Abstract][Full Text] [Related]
7. Severe combined immune deficiencies due to defects of the common gamma chain-JAK3 signaling pathway. Candotti F; O'Shea JJ; Villa A Springer Semin Immunopathol; 1998; 19(4):401-15. PubMed ID: 9618765 [No Abstract] [Full Text] [Related]
8. The role of Jak3 in lymphoid development, activation, and signaling. Thomis DC; Berg LJ Curr Opin Immunol; 1997 Aug; 9(4):541-7. PubMed ID: 9287175 [TBL] [Abstract][Full Text] [Related]
9. Jak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs. Pesu M; Candotti F; Husa M; Hofmann SR; Notarangelo LD; O'Shea JJ Immunol Rev; 2005 Feb; 203():127-42. PubMed ID: 15661026 [TBL] [Abstract][Full Text] [Related]
10. Combined immunodeficiencies due to defects in signal transduction: defects of the gammac-JAK3 signaling pathway as a model. Notarangelo LD; Giliani S; Mella P; Schumacher RF; Mazza C; Savoldi G; Rodriguez-Pérez C; Badolato R; Mazzolari E; Porta F; Candotti F; Ugazio AG Immunobiology; 2000 Aug; 202(2):106-19. PubMed ID: 10993286 [TBL] [Abstract][Full Text] [Related]
11. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Russell SM; Tayebi N; Nakajima H; Riedy MC; Roberts JL; Aman MJ; Migone TS; Noguchi M; Markert ML; Buckley RH; O'Shea JJ; Leonard WJ Science; 1995 Nov; 270(5237):797-800. PubMed ID: 7481768 [TBL] [Abstract][Full Text] [Related]
12. Mutations in the gene for the IL-7 receptor result in T(-)B(+)NK(+) severe combined immunodeficiency disease. Puel A; Leonard WJ Curr Opin Immunol; 2000 Aug; 12(4):468-73. PubMed ID: 10899029 [TBL] [Abstract][Full Text] [Related]
13. In vitro correction of JAK3-deficient severe combined immunodeficiency by retroviral-mediated gene transduction. Candotti F; Oakes SA; Johnston JA; Notarangelo LD; O'Shea JJ; Blaese RM J Exp Med; 1996 Jun; 183(6):2687-92. PubMed ID: 8676091 [TBL] [Abstract][Full Text] [Related]
14. A novel JAK3 mutation in a Japanese patient with severe combined immunodeficiency. Uchiyama T; Kumaki S; Fujiwara M; Nishida Y; Hakozaki I; Imai K; Du W; Yoshinari M; Sasahara Y; Tsuchiya S Pediatr Int; 2005 Oct; 47(5):575-8. PubMed ID: 16190968 [No Abstract] [Full Text] [Related]
15. Monocyte function in a severe combined immunodeficient patient with a donor splice site mutation in the Jak3 gene. Villa A; Sironi M; Macchi P; Matteucci C; Notarangelo LD; Vezzoni P; Mantovani A Blood; 1996 Aug; 88(3):817-23. PubMed ID: 8704236 [TBL] [Abstract][Full Text] [Related]
16. Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain. Cacalano NA; Migone TS; Bazan F; Hanson EP; Chen M; Candotti F; O'Shea JJ; Johnston JA EMBO J; 1999 Mar; 18(6):1549-58. PubMed ID: 10075926 [TBL] [Abstract][Full Text] [Related]
17. Impaired IL-7 signaling may explain a case of atypical JAK3-SCID. Li J; Nara H; Rahman M; Juliana FM; Araki A; Asao H Cytokine; 2010 Feb; 49(2):221-8. PubMed ID: 19889552 [TBL] [Abstract][Full Text] [Related]
18. Of genes and phenotypes: the immunological and molecular spectrum of combined immune deficiency. Defects of the gamma(c)-JAK3 signaling pathway as a model. Notarangelo LD; Giliani S; Mazza C; Mella P; Savoldi G; Rodriguez-Pérez C; Mazzolari E; Fiorini M; Duse M; Plebani A; Ugazio AG; Vihinen M; Candotti F; Schumacher RF Immunol Rev; 2000 Dec; 178():39-48. PubMed ID: 11213805 [TBL] [Abstract][Full Text] [Related]
19. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Puel A; Ziegler SF; Buckley RH; Leonard WJ Nat Genet; 1998 Dec; 20(4):394-7. PubMed ID: 9843216 [TBL] [Abstract][Full Text] [Related]
20. Molecular diagnosis of severe combined immunodeficiency--identification of IL2RG, JAK3, IL7R, DCLRE1C, RAG1, and RAG2 mutations in a cohort of Chinese and Southeast Asian children. Lee PP; Chan KW; Chen TX; Jiang LP; Wang XC; Zeng HS; Chen XY; Liew WK; Chen J; Chu KM; Chan LL; Shek L; Lee AC; Yu HH; Li Q; Xu CG; Sultan-Ugdoracion G; Latiff ZA; Latiff AH; Jirapongsananuruk O; Ho MH; Lee TL; Yang XQ; Lau YL J Clin Immunol; 2011 Apr; 31(2):281-96. PubMed ID: 21184155 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]